sellWeak10b5-1 plan
Peter B. Silverman sold $1.3M of MRUS
COO & GC at Merus N.V.. 23,500 shares at an average of $55.00, traded Jul 9, 2025, filed Jul 11, 2025.
Warning score
30Value
$1.3M
23,500 shares
Holdings after
0
-351% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- +25Trade size$1.3M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-095292, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 9, 2025 | MOption exercise Common Shares10b5-1 | +6,695 | $18.61 | $125k | 6,695 | Jul 11, 2025 |
| Jul 9, 2025 | SOpen-market sale Common Shares10b5-1 | -6,695 | $55.00 | $368k | 0 | Jul 11, 2025 |
| Jul 10, 2025 | MOption exercise Common Shares10b5-1 | +16,805 | $18.61 | $313k | 16,805 | Jul 11, 2025 |
| Jul 10, 2025 | SOpen-market sale Common Shares10b5-1 | -16,805 | $55.00 | $924k | 0 | Jul 11, 2025 |
| Jul 9, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -6,695 | $0.00 | $0 | 16,805 | Jul 11, 2025 |
| Jul 10, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -16,805 | $0.00 | $0 | 0 | Jul 11, 2025 |
Related signals
Other insiders at Merus N.V. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | MRUSbuy Merus N.V. | A/s Genmab owner | $7.5B 76,922,983 shares | +106% | |
| 37Weak | MRUSbuy Merus N.V. | A/s Genmab owner | $79M 815,444 shares | +1% | |
| 32Weak | MRUSbuy Merus N.V. | A/s Genmab owner | $27M 278,441 shares | +0% | |
| 27Weak | MRUSbuy Merus N.V. | A/s Genmab owner | $26M 271,547 shares | +0% | |
| 16Weak | MRUSsell Merus N.V. | Harry Shuman VP Controller, PAO | $163k 1,700 shares | -13% | |
| 32Weak | MRUSsell Merus N.V. | Harry Shuman VP Controller, PAO | $796k 8,300 shares | -43% | |
| 30Weak | Merus N.V. | Peter B. Silverman COO & GC | $1.5M 25,000 shares | -100% | |
| 30Weak | Merus N.V. | Peter B. Silverman COO & GC | $1.8M 34,000 shares | -100% | |
| 23Weak | Merus N.V. | Harry Shuman VP Controller, PAO | $3,068 115 shares | -2% | |
| 52Moderate | Merus N.V. | Peter B. Silverman COO & GC | $560k 22,386 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.